Bank of Montreal
ALXO icon

Bank of Montreal’s ALX Oncology ALXO Stock Holding History

Bank of Montreal’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-474,781
Closed -$537K – 3746
2025
Q4 		$537K Hold
474,781
– – ﹤0.01% 2282
2025
Q3 		$869K Sell
474,781
-193,966
-29% -$168K ﹤0.01% 2016
2025
Q2 		$278K Sell
668,747
-13,647
-2% -$6.89K ﹤0.01% 2619
2025
Q1 		$425K Sell
682,394
-144,188
-17% -$173K ﹤0.01% 2296
2024
Q4 		$1.38M Buy
+826,582
New +$1.27M ﹤0.01% 1719
2021
Q2 		– Sell
-513
Closed -$37K – 3672
2021
Q1 		$37K Sell
513
-996
-66% -$78.4K ﹤0.01% 3826
2020
Q4 		$130K Buy
1,509
+1,066
+241% +$64.1K ﹤0.01% 3444
2020
Q3 		$16K Buy
+443
New +$17.4K ﹤0.01% 3915

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Bank of Montreal's ALXO Position: Q1 2026 in Review

Bank of Montreal sold out of ALX Oncology (ALXO) in Q1 2026, closing a stake of 474,781 shares — an estimated $537K sold.

Bank of Montreal first reported a position in ALXO in Q3 2020 and held it in 8 quarters. The position peaked at $1.38M in Q4 2024. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Bank of Montreal reported no remaining ALX Oncology position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 474,781 ALX Oncology shares in Q1 2026, an estimated $537K.
  • Bank of Montreal first reported a position in ALX Oncology in Q3 2020 and held it in 8 quarters.
  • Bank of Montreal's ALX Oncology position peaked at $1.38M in Q4 2024.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.